Lupin Ltd. Reaches New Milestone with 52-Week High Stock Price and Consistent Growth in Pharma Industry
Lupin Ltd., a leading pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on July 29, 2024. According to MarketsMojo, the stock is currently rated as 'Hold' and has outperformed the sector by 0.25%. It has also shown consistent growth and stability, trading higher than its moving averages. In the last year, Lupin Ltd. has shown a remarkable 89.37% growth, showcasing its strong performance in the pharma industry.
Lupin Ltd., a leading pharmaceutical company in the largecap industry, has recently reached a new milestone as its stock price touched a 52-week high on July 29, 2024. This comes as a positive development for the company, which has been gaining momentum in the stock market.
According to MarketsMOJO, a leading stock market analysis and research platform, the current stock call for Lupin Ltd. is 'Hold'. The stock has outperformed the sector by 0.25% and has been on a consecutive gain for the last 2 days, with a 2.51% increase in returns during this period. The stock has also been trading in a narrow range of Rs 15.4, indicating stability in its performance.
In terms of moving averages, Lupin Ltd. is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This further reflects the positive trend in the company's stock performance.
When compared to the overall performance of the Sensex, Lupin Ltd. has shown a remarkable 89.37% growth in the last year, while the Sensex has only grown by 23.42%. This showcases the strong performance of Lupin Ltd. in the pharma industry.
With its consistent growth and positive outlook, Lupin Ltd. continues to be a strong player in the largecap pharma industry. Investors can keep a close eye on the company's stock as it continues to make strides in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
